Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | Pskh1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PSKH1 mRNA | CTD | PMID:36331819 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Pskh1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of PSKH1 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Pskh1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PSKH1 mRNA | CTD | PMID:33387578 | 2-palmitoylglycerol | increases expression | EXP | | 6480464 | 2-palmitoylglycerol results in increased expression of PSKH1 mRNA | CTD | PMID:37199045 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PSKH1 mRNA | CTD | PMID:28628672 | avobenzone | decreases expression | EXP | | 6480464 | avobenzone results in decreased expression of PSKH1 mRNA | CTD | PMID:31016361 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of PSKH1 mRNA | CTD | PMID:22316170 and PMID:26238291 | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of PSKH1 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of PSKH1 promoter | CTD | PMID:27901495 | bisphenol A | increases expression | ISO | Pskh1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of PSKH1 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | Pskh1 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of PSKH1 mRNA | CTD | PMID:34947998 | bisphenol F | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PSKH1 mRNA | CTD | PMID:28628672 | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of PSKH1 mRNA | CTD | PMID:19549813 | CU-O LINKAGE | decreases expression | EXP | | 6480464 | cupric oxide results in decreased expression of PSKH1 mRNA | CTD | PMID:22077320 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of PSKH1 mRNA | CTD | PMID:25562108 | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PSKH1 mRNA | CTD | PMID:28628672 | doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of PSKH1 mRNA | CTD | PMID:29803840 | fenthion | decreases expression | ISO | Pskh1 (Mus musculus) | 6480464 | Fenthion results in decreased expression of PSKH1 mRNA | CTD | PMID:34813904 | gentamycin | decreases expression | ISO | Pskh1 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of PSKH1 mRNA | CTD | PMID:33387578 | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PSKH1 mRNA | CTD | PMID:28628672 | iron dichloride | decreases expression | EXP | | 6480464 | ferrous chloride results in decreased expression of PSKH1 mRNA | CTD | PMID:35984750 | leflunomide | decreases expression | EXP | | 6480464 | leflunomide results in decreased expression of PSKH1 mRNA | CTD | PMID:28988120 | methidathion | decreases expression | ISO | Pskh1 (Mus musculus) | 6480464 | methidathion results in decreased expression of PSKH1 mRNA | CTD | PMID:34813904 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Pskh1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PSKH1 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of PSKH1 mRNA | CTD | PMID:36331819 | pirinixic acid | decreases expression | ISO | Pskh1 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of PSKH1 mRNA | CTD | PMID:20813756 | tamoxifen | decreases expression | ISO | Pskh1 (Mus musculus) | 6480464 | Tamoxifen results in decreased expression of PSKH1 mRNA | CTD | PMID:25123088 | tetrachloromethane | decreases expression | ISO | Pskh1 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in decreased expression of PSKH1 mRNA | CTD | PMID:31150632 | thioacetamide | decreases expression | ISO | Pskh1 (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of PSKH1 mRNA | CTD | PMID:34492290 | trichloroethene | increases expression | ISO | Pskh1 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of PSKH1 mRNA | CTD | PMID:33387578 | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of PSKH1 gene | CTD | PMID:29154799 | vinclozolin | decreases expression | ISO | Pskh1 (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of PSKH1 mRNA | CTD | PMID:23034163 | |